Caseware UK (AP4) 2023.0.135 2023.0.135 2023-04-01trueNo description of principal activityfalseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.22 09865009 2023-04-01 2024-03-31 09865009 2022-04-01 2023-03-31 09865009 2024-03-31 09865009 2023-03-31 09865009 c:Director1 2023-04-01 2024-03-31 09865009 d:CurrentFinancialInstruments 2024-03-31 09865009 d:CurrentFinancialInstruments 2023-03-31 09865009 c:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 09865009 c:FullAccounts 2023-04-01 2024-03-31 09865009 c:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 09865009 c:Micro-entities 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure

Registered number: 09865009










GC Gynaecological Histopathology Consultancy Limited








Unaudited

Financial statements

Information for filing with the registrar

For the year ended 31 March 2024

 
GC Gynaecological Histopathology Consultancy Limited
Registered number: 09865009

Statement of financial position
As at 31 March 2024

2024
2023
£
£


Fixed assets
607
1,047

Current assets
62,130
26,281

Creditors: amounts falling due within one year
(53,011)
(20,688)

Net current assets
 
 
9,119
 
 
5,593

Total assets less current liabilities
9,726
6,640


Net assets
9,726
6,640



Capital and reserves
9,726
6,640


Notes


General information

GC Gynaecological Histopathology Consultancy Limited is a private company, limited by shares, registered in
England and Wales. The Company's registered number is 09865009 and registered office is 1 The Green,
Richmond, Surrey, TW9 1PL.


Average number of employees

The average monthly number of employees, including directors, during the year was 2 (2023 - 2).

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 11 September 2024.




Dr G A Culora
Director


Page 1